Intervention Review

Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus

  1. Nyoli Valentine1,
  2. Floris A Van de Laar2,*,
  3. Mieke L van Driel3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 31 MAY 2011

DOI: 10.1002/14651858.CD005449.pub2

How to Cite

Valentine N, Van de Laar FA, van Driel ML. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD005449. DOI: 10.1002/14651858.CD005449.pub2.

Author Information

  1. 1

    Bond University, Department of General Practice, Gold Coast, Queensland, Australia

  2. 2

    Radboud University Nijmegen Medical Center, Department of Primary and Community Care, 117 ELG, Nijmegen, Netherlands

  3. 3

    The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Queensland, Australia

*Floris A Van de Laar, Department of Primary and Community Care, 117 ELG, Radboud University Nijmegen Medical Center, PO Box 9101, Nijmegen, 6500 HB, Netherlands. f.vandelaar@elg.umcn.nl. f.vandelaar@cochraneprimarycare.org.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH